ProfileGDS5822 / ILMN_2648012
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 17% 4% 37% 33% 24% 12% 52% 23% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11217
GSM1276600PDAC Late Ablation Control 294
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.137
GSM1276603PDAC Late Ablation 216.233
GSM1276604PDAC Late Ablation 313.524
GSM1303940PDAC Late Ablation_anti-CTLA4 110.112
GSM1303941PDAC Late Ablation_anti-CTLA4 227.352
GSM1303942PDAC Late Ablation_anti-CTLA4 311.823